CARL — Carlsmed, Inc.
Carlsmed, Inc., a commercial-stage medical technology company, designs, manufactures, and markets AI-enabled personalized spine surgery solutions. The company develops aprevo, a comprehensive technology platform for spine fusion surgery procedures. Its aprevo platform includes proprietary surgical planning software, using outcomes-based algorithms that are aided with artificial intelligence, and resulting custom-built, anatomically designed vertebral interbody implants. The company was incorporated in 2018 and is based in Carlsbad, California.
Company profile
- Sector: Healthcare
- Industry: Medical - Devices
- Country: US
- Exchange: NASDAQ
- Employees: 100
- Website: https://www.carlsmed.com
Latest SEC filings for CARL
- S-8 — 2026-10-01
- EFFECT — 2026-08-24
- 10-Q — 2026-08-05
- 10-Q — 2026-05-05
- 8-K — 2026-05-05
- ARS — 2026-04-22
- 10-K — 2026-02-25
- 8-K — 2026-02-25
- 8-K — 2026-01-12
- 8-K — 2025-11-06
Latest CARL news
- — Carlsmed Launches aprevo® Lumbar Bi-lateral Posterior System (GlobeNewswire Inc.)
- — Carlsmed Appoints Tony Jarc as Chief Product and AI Officer (globenewswire.com)
- — Carlsmed appoints new CFO, reaffirms 2026 revenue outlook (seekingalpha_market)
- — Carlsmed Appoints Richard Heppenstall as Chief Financial Officer (globenewswire.com)
Educational tool only — not investment advice.